Table 5:
Comparison of cumulative prevalence of fragility fracture in NAPS2 CP patients from UPMC with CP patients in two published US studies
| NAPS-2 Subjects N (%)# |
Tignor et al. 2010 CP Subjects N (%) |
Munigala et al. 2016 CP Subjects N (%) |
|
|---|---|---|---|
| Total patients | 22/227 (9.69) | 120/2573 (4.66) ** | 137/2672 (5.13) * |
| Males | |||
| 45-65 years | 7/86 (8.13) | 32/737 (4.34) | 97/2038 (4.76) |
| > 65 years | 4/41 (9.75) | 18/561 (3.21)* | 35/525 (6.67) |
| Females | |||
| 45-65 years | 5/62 (8.06) | 18/679 (2.65)* | 5/98 (5.10) |
| > 65 years | 6/38 (15.79) | 60/596 (10.07) | 0/11 (0) |
#
Only patients ≥ 45 years at last contact were included in this analysis
**
p-value ≤0.001 and
*
p-value <0.05 for comparisons between NAPS2 CP patients vs. CP patients in other studies